Search

everythinglearnresearchcommunity

for

Search:↓

The skin conditions of Iraqi women changed during the COVID-19 pandemic, with more hair loss and skin irritation but fewer contagious skin infections.

The COVID-19 pandemic led to more hair loss and skin irritation among Iraqi women, with some skin conditions increasing and others decreasing.

Knowing how long skin diseases last is important for better patient care.

Tofacitinib shows promise for treating alopecia areata with significant hair regrowth and mild side effects.

Early diagnosis and coordinated care are crucial for managing lupus effectively.

Alopecia areata and atopic dermatitis share immune system issues, and treatments like JAK inhibitors can help both.

Janus kinase inhibitors help some people with severe alopecia areata regrow hair, but not everyone responds, and relapses can happen.

JAK inhibitors can help treat alopecia areata but have risks and high costs.

Most emerging dermatological treatments lack strong evidence and require more research.

Ritlecitinib effectively regrows scalp, eyebrow, and eyelash hair in Asians with alopecia areata and is safe.

JAK inhibitors show promise for treating various skin disorders effectively and safely.

Discoid lupus erythematosus can be mistaken for a skin infection, complicating diagnosis and treatment.

Ritlecitinib is effective and safe for treating severe alopecia areata in people aged 12 and older.

High CCL11 levels may indicate poor response to baricitinib in severe alopecia areata.

Microneedles improve drug delivery for skin diseases, enhancing treatment effectiveness and patient compliance.

New medications could improve treatment for severe alopecia areata in Australia.

International guidelines for treating alopecia areata vary, focusing on different treatment options and related health issues.

Accurate diagnosis and personalized treatment are crucial in dermatopathology.

Trichodynia is a challenging scalp condition to treat, needing gentle care and more research for better solutions.

Dupilumab and COVID-19 can worsen or trigger psoriasis.

A 50 mg non-loading dose of ritlecitinib is safe for adults and adolescents.

Advancements in diagnostics, treatments, and technology have improved hair loss detection and restoration, with some types being reversible.

Alopecia Areata causes hair loss and needs treatments that address both physical and emotional health.

Telitacicept helped stabilize complement levels in a patient with lupus and thyroid cancer.

Baricitinib is effective for treating severe alopecia areata in Japanese patients, but long-term safety needs more study.

Adding vitamin B12 to food like salt can effectively improve vitamin levels in rural areas.

Anifrolumab treatment improves quality of life and reduces disease activity and steroid use in SLE patients.

Combination pharmacotherapy is generally more effective for treating keloids and hypertrophic scars.

Light exposure is crucial for health, helping prevent and treat illnesses.